In PerkinElmer's largest purchase ever, the Massachusetts-based company is dropping a massive $5.25 billion in cash and stock to buy the biomedical research tool company BioLegend.
Congenica CEO David Atkins recently took time to chat with Clinical OMICs Editor in Chief Chris Anderson about the company’s plans and his views of the...
What are the top NASDAQ genetics stocks year-to-date? We run through the five biggest gainers so far this year. The post Top NASDAQ Genetics Stocks appeared...
The full range of animal species that are susceptible to SARS-CoV-2 infection remains unclear. To fill in some of the gaps, researchers used a repository of...
Six oil investments to buy as the economy improves and energy prices rise are part of an industry that recently led BoA Global Research to forecast...
Expansion plans shared by Regeneron call for the biotech giant to build approximately 900,000 square feet in two phases over six years, consisting of up to...
The rapid increase in demand for mRNA therapeutics has revealed the inherent challenge of the platform—that the production of mRNA is facing a series of bottlenecks....
Scientists collaborate to model the complex protein responsible for SARS-CoV-2 replication, revealing its potential weak spots for drug development Credit: Greg Hura/Berkeley Lab In February 2020,...
The sketchy history of international efforts to control bioweapons suggests that nations will resist cooperative monitoring of gene hacking for medical research.
Here are some of the best biotech stocks worth your attention. The post Top Stocks To Watch This Week? 4 Biotech Stocks To Know appeared first...
New study finds a 17.7 percent rise in COVID-19 cases after a prolonged 2020 wildfire smoke event in Reno, Nev. Credit: U.S. Department of Agriculture Reno,...
Three generic pharmaceutical manufacturers to buy for profitable investing opportunities feature companies that have risen near the top of that sector. The three generic pharmaceutical manufacturers...
Three generic pharmaceutical manufacturers to buy for profitable investing opportunities feature companies that have risen near the top of that sector. The three generic pharmaceutical manufacturers...
A World Health Organization (WHO) committee said on July 12 that human genome editing technologies to treat serious disease should be shared more generously, to allow...
Venture capitalist Bob Nelsen was sitting on his couch two summers ago when he got a call from a famous scientist, who matter-of-factly explained that he...
There exciting developments from gene-editing companies are sending bullish waves across the space. The post What Are The Best Stocks To Invest In? 5 Gene Editing...
A team of researchers uncovers how the COVID-19 vaccines that use adenovirus vectors trigger the rare, blood clotting reaction known as VITT. They showed that VITT...
These healthcare companies are fighting disease and improving the standard of care. The post Best Stocks To Buy Today? 4 Health Care Stocks To Watch appeared...
Could new cancer treatment breakthroughs be a bullish sign for small cap stocks? The post Hot Small-Cap Stocks To Watch With Potential Cancer Breakthroughs appeared first...
A metabolic control pathway that regulates T follicular helper cells offers targets for drugs to stimulate the adaptive immune response Credit: St. Jude Children’s Research Hospital...
Five biopharmaceutical stocks to buy to seize upon genetic advances still appear to have room for plenty of appreciation, according to seasoned market trackers who I...
After the FDA handed Novartis a complete response letter for its PCSK9 drug inclisiran in December due to manufacturing deficiencies with its Italian CDMO partner, the...
Check out these 3 top biotech stocks breaking new ground in the industry now. The post Best Biotech Stocks To Buy In July 2021? 3 To...
A team at the Wyss Institute has embedded synthetic biology reactions into fabrics, creating wearable biosensors that can be customized to detect pathogens and toxins. The...
Looking beyond this year, synthetic biology is expected to more than triple in size as an industry from $9.5 billion this year to $30.7 billion, according...
Manufacturing partnership intended to enable suspension-based manufacture of gene therapies and viral vector-based vaccines. The post Pall Inks $7 Million+ Deal with Exothera appeared first on...
Sponsored Content From: From the early stages of the emergence of SARS-CoV-2, researchers have used real-time nanopore sequencing to generate and share genetic data critical to...
A study at the University of Oxford has looked at what happens when people receive one dose of AstraZeneca one dose of Pfizer.
Watch: House Subcommittee Hears Chinese Military Ran Wuhan Lab; Experts Warn It's "Highly Likely" COVID-19 Leaked Authored by Steve Watson via Summit News, Republicans in the...
Thanks to unprecedented development speed and mostly strong safety and efficacy data, vaccines have dominated the response to COVID-19. Seven COVID-19 drugs have shown promise recently....